نتایج جستجو برای: ebola haemorrhagic fever
تعداد نتایج: 105351 فیلتر نتایج به سال:
A 3-month ecologic investigation was done to identify the reservoir of Ebola virus following the 1995 outbreak in Kikwit, Democratic Republic of the Congo. Efforts focused on the fields where the putative primary case had worked but included other habitats near Kikwit. Samples were collected from 3066 vertebrates and tested for the presence of antibodies to Ebola (subtype Zaire) virus: All test...
1. Centro Universitário Cesumar – Unicesumar – Maringá (PR) Brasil. 2. Programa de Pós-Graduação em Ciências da Saúde, Universidade Estadual de Maringá, Maringá (PR) Brasil. 3. Hospital Paraná, Maringá (PR) Brasil. 4. University of Louisville School of Medicine, Louisville (KY) USA. 5. Laboratório de Micologia Médica, Departamento de Análises Clínicas, Universidade Estadual de Maringá, Maringá ...
The 2014 outbreak of Ebola virus disease (EVD) in West Africa, caused by Ebola virus (Zaire Ebola virus species), is the largest outbreak of EVD in history. It cause hemorrhagic fever in human and nonhuman primates with high mortality rate up to 90% and can be transmitted by direct contact with blood, body fluids, skin of EVD patients or persons who have died of EVD. As of December 17, 2014, 45...
Despite its isolation three decades ago, Ebola virus continues to cause periodic outbreaks of severe hemorrhagic fever in humans, and the closely related Marburg virus is responsible for a recent outbreak of disease in Angola. The mortality rate associated with Ebola virus infection can reach 90 percent, and so the prospect of an effective therapy is attractive. A recent study by Chandran et al. 1
BACKGROUND Ebola Virus Disease (Ebola) is a viral hemorrhagic fever that causes severe illness and can be fatal. Symptoms present 2 to 21 days after exposure to the Ebola virus and include: sudden onset of fever, severe headache, muscle pain, weakness, and fatigue, followed by vomiting, diarrhea, abdominal pain and unexplained bleeding or bruising.1 In December 2013, an outbreak of Ebola began ...
BACKGROUND Effective countermeasures are urgently needed to prevent and treat infections caused by highly pathogenic and biological threat agents such as Marburg virus (MARV). We aimed to test the efficacy of a replication-competent vaccine based on attenuated recombinant vesicular stomatitis virus (rVSV), as a postexposure treatment for MARV haemorrhagic fever. METHODS We used a rhesus macaq...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید